Clinical Trial

Polyethylene Wear Particle Analysis of THA

Recruiting
View on ClinicalTrials.gov →
Summary
Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and widely used clinically, but whose mid- to long-term clinical results are still unknown, is superior to conventional polyethylene in vivo. The aim of this project is to conduct an international multi-center joint research study to determine whether polyethylene wear debris production can be reduced in the future, using an in vivo polyethylene wear debris analysis method that the investigators developed as a method that can provide early feedback.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-22; most recent amendment 2025-01-16.
Status change: Not Yet Recruiting → Recruiting 2025-01-16
Trial Details
NCT Number NCT06432543
Lead Sponsor Osaka Metropolitan University
Collaborators: Mayo Clinic, Hospital for Special Surgery, New York, Istituto Ortopedico Rizzoli
Conditions Wear of Articular Bearing Surface of Prosthetic Joint, Hip Arthropathy
Enrollment 90 participants
Start Date 2024-06-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-20